Evidence map›Paper›PMID 38406613›Full record

ArticleJournal of clinical and experimental hepatology

Outcomes of Liver Transplant Recipients Hospitalized With COVID-19: A Nationwide Analysis From the United States.

Abdellatif Ismail, Spencer R Goble, Ahmad Khalaf, Ma'in Abumuhfouz, Ruaa Al Sakaa Amini, Neha Jakhete, Kirti Shetty

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdellatif IsmailDepartment of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, 21201, USA.
Spencer R GobleDepartment of Medicine, Hennepin Healthcare, Minneapolis, MN, USA.
Ahmad KhalafDepartment of Medicine, Hennepin Healthcare, Minneapolis, MN, USA.
Ma'in AbumuhfouzDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Ruaa Al Sakaa AminiDepartment of Medicine, Arab Medical Center, Amman, Jordan.
Neha JakheteDivision of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA.
Kirti ShettyDivision of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Currently available data regarding the impact of liver transplantation on the outcomes of patients hospitalized with COVID-19 is conflicting. This study aims to compare the outcomes and resource utilization between patients with and without a history of liver transplant hospitalized with COVID-19. Methods and materials: This is a retrospective study using the National Inpatient Sample. All adults hospitalized with COVID-19 in the year 2020 were included. Mortality was the primary outcome, while endotracheal intubation, length of hospital stay, and total hospital charges were the secondary outcomes. Results: Out of 1,050,720 adults admitted with COVID-19 as the primary diagnosis, 1,455 had a secondary diagnosis of liver transplant. Mortality was not significantly increased in transplant recipients (OR adjusted = 0.69, 95% CI: 0.46-1.03, Conclusion: Liver transplant recipients do not appear to be at increased risk of severe COVID-19 and COVID-19 mortality.

Indexed as

COVID-19liver transplant recipientsnational inpatient sampleSARSCOV-2solid organ transplant

Identifiers

PMID38406613
PMCPMC10882582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.